Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma Total mesorectal excision (TME) for rectal cancer may result ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback